DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakamura, H.
Right arrow Articles by Kitada, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakamura, H.
Right arrow Articles by Kitada, M.

Vol. 31, Issue 4, 432-438, April 2003

CYP3A4 and CYP3A7-Mediated Carbamazepine 10,11-Epoxidation Are Activated by Differential Endogenous Steroids

Hiroyoshi Nakamura, Nao Torimoto, Itsuko Ishii, Noritaka Ariyoshi, Hiromitsu Nakasa, Shigeru Ohmori, and Mitsukazu Kitada

Division of Pharmacy, Chiba University Hospital Inohana, Chuo-ku, Chiba, Japan (H.N., N.A., H.N., M.K.); Graduate School of Pharmaceutical Science, Chiba University Yayoi-cho, inage-ku, Chiba, Japan (N.T., I.I.); and Division of Pharmacy, Shinsyu University Hospital Asahi, Matsumoto, Japan (S.O.)

Recently, we reported that several endogenous steroids affect CYP3A4-mediated drug metabolism, using human adult liver microsomes as an enzyme source. Especially, carbamazepine (CBZ) 10,11-epoxidation is activated by androstenedione (AND). In the present studies, we investigated the effects of endogenous steroids on the activity of CBZ 10,11-epoxidation by expressed CYP3A4 and CYP3A7. When expressed CYP3A4 was used as an enzyme source, the addition of AND to the reaction mixture also caused a drastic increase in the activity of CBZ 10,11-epoxidase, and resulted in a change in the kinetics from sigmoid to Michaelis-Menten type. On the other hand, expressed CYP3A7-mediated CBZ 10,11-epoxidation was activated by sulfate conjugate steroids, such as pregnenolone 3-sulfate, 17alpha -hydroxypregnenolone 3-sulfate, and dehydroepiandrosterone 3-sulfate (DHEA-S), whereas the unconjugated form corresponding to these three steroids did not activate the reaction. Especially, DHEA-S was found to be a potent activator of CBZ 10,11-epoxidation by expressed CYP3A7. The kinetic character of CBZ 10,11-epoxidation by CYP3A7 is Michaelis-Menten type regardless of the presence of DHEA-S. The presence of DHEA-S caused a decrease in Km and increase in Vmax for CYP3A7-mediated CBZ 10,11-epoxidation, whereas DHEA-S 16alpha -hydroxylation was not affected by the coexistence of CBZ. In conclusion, CYP3A4 and CYP3A7-mediated CBZ 10,11-epoxidations are activated by different types of endogenous steroids. This is the first report regarding CYP3A7 cooperativity.


Copyright © 2003 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
J. Henshall, A. Galetin, A. Harrison, and J. B. Houston
Comparative Analysis of CYP3A Heteroactivation by Steroid Hormones and Flavonoids in Different in Vitro Systems and Potential in Vivo Implications
Drug Metab. Dispos., July 1, 2008; 36(7): 1332 - 1340.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
P. Kang, M. Liao, M. R. Wester, J. S. Leeder, R. E. Pearce, and M. A. Correia
CYP3A4-Mediated Carbamazepine (CBZ) Metabolism: Formation of a Covalent CBZ-CYP3A4 Adduct and Alteration of the Enzyme Kinetic Profile
Drug Metab. Dispos., March 1, 2008; 36(3): 490 - 499.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
N. Torimoto, I. Ishii, K.-I. Toyama, M. Hata, K. Tanaka, H. Shimomura, H. Nakamura, N. Ariyoshi, S. Ohmori, and M. Kitada
Helices F-G Are Important for the Substrate Specificities of CYP3A7
Drug Metab. Dispos., March 1, 2007; 35(3): 484 - 492.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. S. Leeder, R. Gaedigk, K. A. Marcucci, A. Gaedigk, C. A. Vyhlidal, B. P. Schindel, and R. E. Pearce
Variability of CYP3A7 Expression in Human Fetal Liver
J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 626 - 635.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.